Product Information
FIDAXOMICIN 200 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $100.0687 per EA under NDC 00480259634. Its NADAC has been published 32 times since Nov 19, 2025.
Strength
200 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480259634
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FIDAXOMICINApproval Type
Generic (ANDA)
FDA Application
ANDA208443On Market Since
7/15/2025
Pharmacological Classes
Price Statistics
The NADAC for FIDAXOMICIN 200 MG TABLET has been published 32 times since Nov 19, 2025, and over the history we have for it it has declined 45.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $100.0687 per EA |
|---|---|
| All-time high | $193.6654 (Apr 15, 2026) |
| All-time low | $100.0687 (Jun 17, 2026) |
| 52-week high | $193.6654 |
| 52-week low | $100.0687 |
| Median price | $183.0270 |
| Average price | $171.7212 |
| Largest weekly change | -23.1% (Jun 17, 2026) |
| Weeks tracked | 32 |
| Tracking since | Nov 19, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FIDAXOMICIN 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FIDAXOMICIN 200 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $100.0687 per EA (NDC 00480259634), effective Jun 24, 2026.
How has the price of FIDAXOMICIN 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for FIDAXOMICIN 200 MG TABLET has declined 45.3%. It has been tracked across 32 weekly CMS publications since Nov 19, 2025.
What are the highest and lowest recorded NADAC prices for FIDAXOMICIN 200 MG TABLET?
Since Nov 19, 2025, the NADAC for FIDAXOMICIN 200 MG TABLET has ranged from a low of $100.0687 (Jun 17, 2026) to a high of $193.6654 (Apr 15, 2026), with a median of $183.0270 per EA.
Are there cheaper alternatives to FIDAXOMICIN 200 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as FIDAXOMICIN 200 MG TABLET, but none are currently priced below it.
Who manufactures FIDAXOMICIN 200 MG TABLET?
FIDAXOMICIN 200 MG TABLET (NDC 00480259634) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification